Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | KDM5A | P29375 | 3/20 | 0.48 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9807773 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL628762 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL10606558 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL1003342 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL516699 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL236922 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL24028136 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL14840251 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL2945945 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 | |
| SCHEMBL21409651 | 1.00 | DNM1 (0.58) | DNM1TSHRTHRBKDM5APHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4165158-B1 | A DISINFECTANT AND CLEANING COMPOSITION | LA SUPERQUIMICA S A (ES) | 2023-11-15 | — | — | EP | claimed |
| WO-2005042675-A2 | METHODS FOR INHIBITING HYDRATE BLOCKAGE IN OIL AND GAS PIPELINES USING SIMPLE QUATERNARY AMMONIUM AND PHOSPHONIUM COMPOUNDS | CHAMPION TECHNOLOGIES, INC. (US) | 2005-05-12 | — | — | WO | claimed |
| US-20050085676-A1 | Methods for inhibiting hydrate blockage in oil and gas pipelines using betaines and amine oxides | CHAMPION TECHNOLOGIES, INC. | 2005-04-21 | — | — | US | claimed |
| EP-4210883-B1 | INVESTMENT CASTING COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-02-14 | — | — | EP | disclosed |
| US-20230348667-A1 | Investment Casting Compositions and Methods | 3M INNOVATIVE PROPERTIES COMPANY | 2023-11-02 | — | — | US | disclosed |
| EP-4210883-A1 | INVESTMENT CASTING COMPOSITIONS AND METHODS | 3M Innovative Properties Company (US) | 2023-07-19 | — | — | EP | disclosed |
| WO-2022053890-A1 | INVESTMENT CASTING COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-03-17 | — | — | WO | disclosed |
| US-11155668-B2 | Contact-killing, QAC functionalized thermoplastic polyurethane for catheter applications | THE UNIVERSITY OF AKRON (US) | 2021-10-26 | — | — | US | disclosed |
| US-10450402-B2 | Polyester polyol-containing polyurethane systems having improved hydrolytic stability | EVONIK DEGUSSA GMBH (DE) | 2019-10-22 | — | — | US | disclosed |
| EP-3508510-A1 | CONTACT-KILLING, QAC FUNCTIONALIZED THERMOPLASTIC POLYURETHANE FOR CATHETER APPLICATIONS | The University of Akron (US) | 2019-07-10 | — | — | EP | disclosed |
| US-20190106525-A1 | CONTACT-KILLING, QAC FUNCTIONALIZED THERMOPLASTIC POLYURETHANE FOR CATHETER APPLICATIONS | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2019-04-11 | — | — | US | disclosed |
| US-20050085676-A1 | Methods for inhibiting hydrate blockage in oil and gas pipelines using betaines and amine oxides | CHAMPION TECHNOLOGIES, INC. | 2005-04-21 | — | — | US | disclosed |
| US-20050085675-A1 | Methods for inhibiting hydrate blockage in oil and gas pipelines using ester compounds | CHAMPION TECHNOLOGIES, INC. | 2005-04-21 | — | — | US | disclosed |
| US-20050081714-A1 | Methods for inhibiting hydrate blockage in oil and gas pipelines using simple quaternary ammonium and phosphonium compounds | HARBISON-FISCHER, INC. | 2005-04-21 | — | — | US | disclosed |
| US-20050081432-A1 | Methods for inhibiting hydrate blockage in oil and gas pipelines using amide compounds | CLARIANT INTERNATIONAL LTD. (CH) | 2005-04-21 | — | — | US | disclosed |
| EP-0323163-B1 | SHIFT-FEEL DURABILITY ENHANCEMENT | ETHYL PETROLEUM ADDITIVES, INC. (US) | 1991-05-29 | — | — | EP | disclosed |
| EP-0323163-A1 | Shift-feel Durability enhancement | ETHYL PETROLEUM ADDITIVES, INC. (US) | 1989-07-05 | — | — | EP | disclosed |
| US-4795583-A | FRICTION MODIFIER FOR AUTOMATIC TRANSMISSION FLUIDS CONTAINING AN ALIPHATIC TERTIARY AMINE, ALIPHATIC DIAMINE AND-OR N-SUBSTITUTED DIALKANOLAMINE | ETHYL PETROLEUM ADDITIVES, INC. (US) | 1989-01-03 | — | — | US | disclosed |
| US-4250115-A | Preparation of tertiary amines | UOP INC. (US) | 1981-02-10 | — | — | US | disclosed |
| US-4207260-A | Preparation of tertiary amines | UOP INC. (US) | 1980-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11155668-B2 | Contact-killing, QAC functionalized thermoplastic polyurethane for catheter applications | QARS1, DDC, AADAC | DNM1 599/4885TSHR 3862/4885THRB 3691/4885 |
| US-20190106525-A1 | CONTACT-KILLING, QAC FUNCTIONALIZED THERMOPLASTIC POLYURETHANE FOR CATHETER APPLICATIONS | QARS1, DDC, AADAC | DNM1 599/4885TSHR 3862/4885THRB 3691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.